熱門資訊> 正文
FibroBiologics宣布任命CFO
2025-06-09 20:42
- FibroBiologics (NASDAQ:FBLG) announced the appointment of Jason D. Davis, CPA, as chief financial officer, effective immediately.
- Davis most recently served as CFO of Virax Biolabs (VRAX).
- FBLG shares up 1.1% premarket on Monday.
- Source: Press release
More on FibroBiologics
- Seeking Alpha’s Quant Rating on FibroBiologics
- Historical earnings data for FibroBiologics
- Financial information for FibroBiologics
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。